Hereditary angioedema: A decade of management with stanozolol*
References (18)
- et al.
Clinical and biochemical effects of impeded androgen (oxymetholone) therapy of hereditary angioedema
J Allergy Clin Immunol
(1979) - et al.
Clinical and biochemical effects of stanozolol therapy for hereditary angioedema
J Allergy Clin Immunol
(1981) - et al.
Morphologic evaluation of the liver in hereditary angioedema patients on long-term treatment with androgen derivatives
J Alleroy Clin Immunol
(1983) Methyltestosterone therapy for hereditary episodic edema (hereditary angioneurotic edema)
Ann Intern Med
(1960)- et al.
Long-term therapy of hereditary angioedema (HAE)
Johns Hopkins Med J
(1974) - et al.
Treatment of hereditary angioedema with danazol: reversal of clinical and biochemical abnormalities
N Engl J Med
(1976) - et al.
The effect of synthetic androgens in hereditary angioneurotic edema: alteration of C1 inhibitor and C4 levels
Trans Assoc Am Physicians
(1976) - et al.
Methyltestosterone therapy in hereditary angioedema
Ann Intern Med
(1977) - et al.
Remissions induced in hereditary angioneurotic edema with an attenuated androgen (danazol): correlation between concentrations of C1 inhibitor and the fourth and second components of complement
J Lab Clin Med
(1978)
Cited by (66)
US HAEA Medical Advisory Board 2020 Guidelines for the Management of Hereditary Angioedema
2021, Journal of Allergy and Clinical Immunology: In PracticeProphylactic Therapy for Hereditary Angioedema
2017, Immunology and Allergy Clinics of North AmericaCritical appraisal of androgen use in hereditary angioedema: A systematic review
2015, Annals of Allergy, Asthma and ImmunologyCitation Excerpt :Two pediatric patients (aged 11 and 14 years) received danazol, 300 mg, day 4 days before and 4 days after dental extraction, with no exacerbation of HAE.45 On the basis of data from prospective studies, the most commonly reported adverse events associated with androgen therapy for HAE include weight gain, menstrual irregularities, virilization, headaches, myalgias or cramps, and mood changes (eg, depression and anxiety) (eTable 2).15,17,20,22–25 In general, more prolonged use and higher doses were associated with an increased risk of adverse events.
A focused parameter update: Hereditary angioedema, acquired C1 inhibitor deficiency, and angiotensin-converting enzyme inhibitor-associated angioedema
2013, Journal of Allergy and Clinical ImmunologyInternational consensus on hereditary and acquired angioedema
2012, Annals of Allergy, Asthma and Immunology
- *
Supported by National Institutes of Health Grants AI-22531, AI-23401, HL-36110, AM-35907, and RR-05669.
- 1
From the Department of Medicine, Harvard Medical School, and the Department of Rheumatology/Immunology, Brigham and Women's Hospital, Boston, Mass.